Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation
- Author
- ROMAN, José1 ; ALVAREZ, Miguel Angel1 ; TORRES, Antonio1
[1] Hematology Department, Reina Sofía Hospital, Córdoba, Spain - Source
Haematologica (Roma). 2000, Vol 85, Num 10, pp 1072-1082 ; ref : 83 ref
- ISSN
- 0390-6078
- Scientific domain
- Hematology
- Publisher
- Haematologica, Pavia
- Publication country
- Italy
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cellule hématopoïétique Cellule souche Chromosome Ph1 Chronique Diagnostic Donneur Gène hybride Homme Homogreffe Leucémie myéloïde Lymphocyte Maladie greffon hôte Maladie résiduelle imperceptible Moelle osseuse Réaction chaîne polymérase Récidive Surveillance biologique Traitement Transfusion Translocation chromosomique Gène abl Gène bcr Aberration chromosomique Biologie moléculaire Chromosome anormal Greffe Hémopathie maligne Myéloprolifératif syndrome
- Keyword (en)
- Hematopoietic cell Stem cell Philadelphia chromosome Chronic Diagnosis Donor Hybrid gene Human Homograft Chronic myelocytic leukemia Lymphocyte Graft versus host reaction Minimal residual disease Bone marrow Polymerase chain reaction Relapse Biological monitoring Treatment Transfusion Chromosome translocation Chromosomal aberration Molecular biology Abnormal chromosome Graft Malignant hemopathy Myeloproliferative syndrome
- Keyword (es)
- Célula hematopoyética Célula primitiva Cromosoma Ph1 Crónico Diagnóstico Donador Gen híbrido Hombre Homoinjerto Leucemia mieloidea Linfocito Enfermedad injerto huesped Enfermedad residual imperceptible Médula ósea Reacción cadena polimerasa Recaida Vigilancia biológica Tratamiento Transfusión Translocación cromosómica Aberración cromosómica Biología molecular Cromosoma anormal Injerto Hemopatía maligna Mieloproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 828398
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"85\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1072\";s:8:\"\u0000*\u0000epage\";s:4:\"1082\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ROMAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jos\u00e9\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:21:\"ALVAREZ, Miguel Angel\";i:1;s:15:\"TORRES, Antonio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"85\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1072\";s:8:\"\u0000*\u0000epage\";s:4:\"1082\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ROMAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jos\u00e9\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:21:\"ALVAREZ, Miguel Angel\";i:1;s:15:\"TORRES, Antonio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"85\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1072\";s:8:\"\u0000*\u0000epage\";s:4:\"1082\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ROMAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jos\u00e9\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:21:\"ALVAREZ, Miguel Angel\";i:1;s:15:\"TORRES, Antonio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"85\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1072\";s:8:\"\u0000*\u0000epage\";s:4:\"1082\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ROMAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jos\u00e9\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:21:\"ALVAREZ, Miguel Angel\";i:1;s:15:\"TORRES, Antonio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"85\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"1072\";s:8:\"\u0000*\u0000epage\";s:4:\"1082\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ROMAN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jos\u00e9\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:21:\"ALVAREZ, Miguel Angel\";i:1;s:15:\"TORRES, Antonio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
